HNWAG
REGN icon

High Net Worth Advisory Group’s Regeneron Pharmaceuticals REGN Stock Holding History

High Net Worth Advisory Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-302
Closed -$215K – 221
2024
Q4 		$215K Hold
302
– – 0.06% 208
2024
Q3 		$317K Hold
302
– – 0.09% 167
2024
Q2 		$317K Hold
302
– – 0.1% 152
2024
Q1 		$291K Hold
302
– – 0.09% 166
2023
Q4 		$265K Hold
302
– – 0.1% 159
2023
Q3 		$249K Hold
302
– – 0.1% 158
2023
Q2 		$217K Buy
302
+26
+9% +$20K 0.08% 181
2023
Q1 		$227K Buy
276
+26
+10% +$19.6K 0.09% 168
2022
Q4 		$180K Hold
250
– – 0.07% 195
2022
Q3 		$172K Hold
250
– – 0.07% 194
2022
Q2 		$148K Hold
250
– – 0.06% 209
2022
Q1 		$175K Hold
250
– – 0.06% 200
2021
Q4 		$158K Buy
+250
New +$154K 0.06% 208

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return